These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12968198)

  • 21. Beta blockers in systolic heart failure.
    Jackowski L; Azam R
    Aust Fam Physician; 2008 Mar; 37(3):137-9. PubMed ID: 18345362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
    Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
    Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland.
    Murphy NF; Simpson CR; McAlister FA; Stewart S; MacIntyre K; Kirkpatrick M; Chalmers J; Redpath A; Capewell S; McMurray JJ
    Heart; 2004 Oct; 90(10):1129-36. PubMed ID: 15367505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practical approach to the management of heart failure.
    DiBianco R
    Aust Fam Physician; 1993 May; 22(5):764, 768-75, 780-1 passim. PubMed ID: 8517820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic heart failure.
    Poole-Wilson PA
    Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E2. PubMed ID: 18297148
    [No Abstract]   [Full Text] [Related]  

  • 27. Advanced heart failure: a call to action.
    Russell SD; Miller LW; Pagani FD
    Congest Heart Fail; 2008; 14(6):316-21. PubMed ID: 19076855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians.
    Remme WJ; McMurray JJ; Hobbs FD; Cohen-Solal A; Lopez-Sendon J; Boccanelli A; Zannad F; Rauch B; Keukelaar K; Macarie C; Ruzyllo W; Cline C;
    Eur Heart J; 2008 Jul; 29(14):1739-52. PubMed ID: 18506054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The less familiar side of heart failure: symptomatic diastolic dysfunction.
    Morris SA; Van Swol M; Udani B
    J Fam Pract; 2005 Jun; 54(6):501-11. PubMed ID: 15939000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
    Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
    Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal treatment of hypertension with diastolic heart failure.
    Susic D; Frohlich ED
    Heart Fail Clin; 2008 Jan; 4(1):117-24. PubMed ID: 18313629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing congestive heart failure in a general hospital in Malaysia. Are we keeping pace with evidence?
    Chin SP; Sapari S; How SH; Sim KH
    Med J Malaysia; 2006 Aug; 61(3):278-83. PubMed ID: 17240575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis.
    Smith DG; Cerulli A; Frech FH
    Clin Ther; 2005 Jun; 27(6):951-9. PubMed ID: 16117995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translating guidelines into clinical practice: benefits of an acute heart failure unit .
    Fonseca C; Ceia F; Sarmento PM; Marques F; Covas R; Aleixo A
    Rev Port Cardiol; 2007 Nov; 26(11):1111-28. PubMed ID: 18297836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure with preserved systolic function: giving well-deserved attention to the "other" heart failure.
    Albert NM
    Crit Care Nurs Q; 2007; 30(4):287-96; quiz 297-8. PubMed ID: 17873564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congestive heart failure.
    Prairie Rose; 2007; 76(2):20-1; quiz 23. PubMed ID: 17542148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.